Sign in

Markets

Overview
News
World markets
Treasuries
Currencies
Commodities
Economy

Stocks

Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers

ETFs

Overview
Popular funds
Most active
Gainers
Losers
News

Research

Search
Sectors

Tools

My watchlist
My portfolio
Recent quotes

Gemina Laboratories Ltd (CSE:GLAB)

0.0300 UNCHANGED

Last Price Updated: 9:30 AM EDT, Mar 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gemina Laboratories Ltd

< Previous 1 2 Next >

News headline image

Gemina Laboratories Announces Private Placement

November 13, 2024

News headline image

Gemina Laboratories Strategic Update

July 10, 2024

News headline image

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

June 21, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

News headline image

Gemina Laboratories Commences Trading on the OTCQB Market in the United States

June 20, 2024

News headline image

Life Sciences Virtual Investor Forum Agenda Announced for June 20th

June 18, 2024

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

News headline image

Gemina Labs Announces Addition to its IP Portfolio

April 09, 2024

News headline image

Gemina Labs to Present at the Life Science Investor Forum June 20th

June 17, 2024

Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

News headline image

Gemina Laboratories Sign First Strategic License Agreement

April 02, 2024

News headline image

Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships

March 21, 2024

News headline image

Gemina Announces Closing of $910,000 Convertible Note Financing

March 19, 2024

News headline image

Gemina Laboratories to Participate in Poster Session at American Association of Clinical Chemistry Annual Scientific Meeting

June 15, 2023

News headline image

Gemina's Recent Investment into RAPIvD Sees Immediate Progress

December 13, 2022

ReadyGo Diagnostics Initiates An Assay Development Contract With Gemina Laboratories For The Detection Of Dengue From Saliva Samples

October 10, 2023

News headline image

Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose

July 25, 2023

News headline image

Gemina Laboratories and ReadyGo Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva

June 05, 2023

News headline image

Gemina Labs Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement

May 17, 2023

News headline image

Gemina Laboratories to Host Investor Webinar on March 30, 2023

March 27, 2023

News headline image

Gemina Labs Appoints Diagnostic Strategist Martha Najib to the Board

March 07, 2023

News headline image

Gemina Labs Announces Appointment of Healthcare Industry Leader Dr. Bola Grace to The Board of Directors

January 25, 2023

News headline image

Gemina Labs Appoints Top Ranked UK Analyst and Scientist, Dr. Stefan Hamill as Vice President, Strategy

January 23, 2023

News headline image

Gemina Labs Strategic Update: Respiratory Infections the Immediate Focus and New Strategic Partnerships on the Horizon

January 10, 2023

News headline image

Gemina Labs Completes Influenza A/B Diagnostic Test Prototype

January 06, 2023

News headline image

Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board

December 20, 2022

News headline image

Gemina Labs Announces Research Collaboration on Next Generation Biosensors

December 19, 2022

News headline image

Gemina Labs Announces Strategic Stake in British Rapid Test Optimizer Rapivd Limited

December 07, 2022

News headline image

Gemina Labs Enters into Licence and Manufacturing Agreements

October 06, 2022

News headline image

Gemina Labs Presents at the H.C. Wainwright Global Investment Conference

September 12, 2022

News headline image

Gemina Labs Appoints Diagnostic Executive Brian Firth as Chief Executive Officer

September 06, 2022

News headline image

Gemina Labs Announces Closing Of Concurrent Private Placement

July 11, 2022

VANCOUVER, BC / ACCESSWIRE / July 11, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the closing of its previously announced non-brokered private...

From Gemina Laboratories Ltd.

News headline image

Gemina Announces Closing Of Prospectus Supplement Offering And Update To Concurrent Non-brokered Private Placement

June 30, 2022

VANCOUVER, BC / ACCESSWIRE / June 30, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB)(FRA:8I7) is pleased to announce that the Company has closed its previously announced...

From Gemina Laboratories Ltd.

< Previous 1 2 Next >

© 2026 FinancialContent Services, Inc. All rights reserved.

Privacy Policy Terms of Service About

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.